Copyright Reports & Markets. All rights reserved.

Global Osimertinib Mesylate Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Osimertinib Mesylate Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Original Drug
    • 1.3.3 Generic Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Osimertinib Mesylate Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Other
  • 1.5 Global Osimertinib Mesylate Tablets Market Size & Forecast
    • 1.5.1 Global Osimertinib Mesylate Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Osimertinib Mesylate Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Osimertinib Mesylate Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Osimertinib Mesylate Tablets Product and Services
    • 2.1.4 AstraZeneca Osimertinib Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Zydus
    • 2.2.1 Zydus Details
    • 2.2.2 Zydus Major Business
    • 2.2.3 Zydus Osimertinib Mesylate Tablets Product and Services
    • 2.2.4 Zydus Osimertinib Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Zydus Recent Developments/Updates
  • 2.3 Drug International
    • 2.3.1 Drug International Details
    • 2.3.2 Drug International Major Business
    • 2.3.3 Drug International Osimertinib Mesylate Tablets Product and Services
    • 2.3.4 Drug International Osimertinib Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Drug International Recent Developments/Updates
  • 2.4 Beacon
    • 2.4.1 Beacon Details
    • 2.4.2 Beacon Major Business
    • 2.4.3 Beacon Osimertinib Mesylate Tablets Product and Services
    • 2.4.4 Beacon Osimertinib Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Beacon Recent Developments/Updates
  • 2.5 General Pharmaceuticals
    • 2.5.1 General Pharmaceuticals Details
    • 2.5.2 General Pharmaceuticals Major Business
    • 2.5.3 General Pharmaceuticals Osimertinib Mesylate Tablets Product and Services
    • 2.5.4 General Pharmaceuticals Osimertinib Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 General Pharmaceuticals Recent Developments/Updates
  • 2.6 Pharmacil
    • 2.6.1 Pharmacil Details
    • 2.6.2 Pharmacil Major Business
    • 2.6.3 Pharmacil Osimertinib Mesylate Tablets Product and Services
    • 2.6.4 Pharmacil Osimertinib Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pharmacil Recent Developments/Updates
  • 2.7 Wanbang Biopharmaceuticals
    • 2.7.1 Wanbang Biopharmaceuticals Details
    • 2.7.2 Wanbang Biopharmaceuticals Major Business
    • 2.7.3 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Product and Services
    • 2.7.4 Wanbang Biopharmaceuticals Osimertinib Mesylate Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Wanbang Biopharmaceuticals Recent Developments/Updates

3 Competitive Environment: Osimertinib Mesylate Tablets by Manufacturer

  • 3.1 Global Osimertinib Mesylate Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Osimertinib Mesylate Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Osimertinib Mesylate Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Osimertinib Mesylate Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Osimertinib Mesylate Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Osimertinib Mesylate Tablets Manufacturer Market Share in 2025
  • 3.5 Osimertinib Mesylate Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Osimertinib Mesylate Tablets Market: Region Footprint
    • 3.5.2 Osimertinib Mesylate Tablets Market: Company Product Type Footprint
    • 3.5.3 Osimertinib Mesylate Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Osimertinib Mesylate Tablets Market Size by Region
    • 4.1.1 Global Osimertinib Mesylate Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Osimertinib Mesylate Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Osimertinib Mesylate Tablets Average Price by Region (2021-2032)
  • 4.2 North America Osimertinib Mesylate Tablets Consumption Value (2021-2032)
  • 4.3 Europe Osimertinib Mesylate Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Osimertinib Mesylate Tablets Consumption Value (2021-2032)
  • 4.5 South America Osimertinib Mesylate Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Osimertinib Mesylate Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Osimertinib Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Osimertinib Mesylate Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Osimertinib Mesylate Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Osimertinib Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Osimertinib Mesylate Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Osimertinib Mesylate Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Osimertinib Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Osimertinib Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Osimertinib Mesylate Tablets Market Size by Country
    • 7.3.1 North America Osimertinib Mesylate Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Osimertinib Mesylate Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Osimertinib Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Osimertinib Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Osimertinib Mesylate Tablets Market Size by Country
    • 8.3.1 Europe Osimertinib Mesylate Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Osimertinib Mesylate Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Osimertinib Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Osimertinib Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Osimertinib Mesylate Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Osimertinib Mesylate Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Osimertinib Mesylate Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Osimertinib Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Osimertinib Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Osimertinib Mesylate Tablets Market Size by Country
    • 10.3.1 South America Osimertinib Mesylate Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Osimertinib Mesylate Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Osimertinib Mesylate Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Osimertinib Mesylate Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Osimertinib Mesylate Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Osimertinib Mesylate Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Osimertinib Mesylate Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Osimertinib Mesylate Tablets Market Drivers
  • 12.2 Osimertinib Mesylate Tablets Market Restraints
  • 12.3 Osimertinib Mesylate Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Osimertinib Mesylate Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Osimertinib Mesylate Tablets
  • 13.3 Osimertinib Mesylate Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Osimertinib Mesylate Tablets Typical Distributors
  • 14.3 Osimertinib Mesylate Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Osimertinib Mesylate Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Osimertinib mesylate tablets are a medication used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations.These tablets are designed to inhibit the activity of the mutated EGFR, thereby slowing down or stopping cancer cell growth,which are often prescribed for patients with advanced or metastatic NSCLC who have developed resistance to other EGFR-targeted therapies.
    This report is a detailed and comprehensive analysis for global Osimertinib Mesylate Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Osimertinib Mesylate Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Osimertinib Mesylate Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Osimertinib Mesylate Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Osimertinib Mesylate Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Osimertinib Mesylate Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Osimertinib Mesylate Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Zydus, Drug International, Beacon, General Pharmaceuticals, Pharmacil, Wanbang Biopharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Osimertinib Mesylate Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Original Drug
    Generic Drug
    Market segment by Application
    Hospital and Clinic
    Retail Pharmacies
    Other
    Major players covered
    AstraZeneca
    Zydus
    Drug International
    Beacon
    General Pharmaceuticals
    Pharmacil
    Wanbang Biopharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Osimertinib Mesylate Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Osimertinib Mesylate Tablets, with price, sales quantity, revenue, and global market share of Osimertinib Mesylate Tablets from 2021 to 2026.
    Chapter 3, the Osimertinib Mesylate Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Osimertinib Mesylate Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Osimertinib Mesylate Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Osimertinib Mesylate Tablets.
    Chapter 14 and 15, to describe Osimertinib Mesylate Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now